Tharimmune, Inc.
USD3.54
+0.22 (+6.63%)
CEO
Mark Wendland
IPO Date
2022-01-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.34
Prev. Close
$3.32
Day Low
$3.32
Day High
$3.58
52W Low
$0.95
52W High
$9.08
Market Cap
$0.14B
Volume
0.36M
| -0.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -102.1% | -85.1% | 0.00 | 6.03 | -0.1 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -152.8% | -126.7% | 0.00 | 5.84 | -0.5 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 47.1% | -355.0% | -0.46 | 0.14 | -17.9 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 65.0% | -820.0% | -0.50 | 0.11 | -14.8 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 94.0% | -3731.5% | -0.59 | 0.04 | -23.5 |
| -0.8 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -34.1% | -27.3% | 0.00 | 4.98 | -2.1 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -505.0% | -73.3% | 0.68 | 1.17 | -0.8 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 312.0% | -153.0% | -0.33 | 0.67 | -0.3 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -292.2% | -102.7% | 0.00 | 1.54 | -0.3 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -125.8% | -72.3% | 0.03 | 2.30 | -0.3 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -34.7% | -28.2% | 0.03 | 5.24 | -0.4 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -32.0% | -25.4% | 0.04 | 4.84 | -0.6 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -27.1% | -22.6% | 0.00 | 6.03 | -0.6 |